Wnt/Planar cell polarity signaling: A new paradigm for cancer therapy

178Citations
Citations of this article
253Readers
Mendeley users who have this article in their library.

Abstract

The evolutionarily conserved and developmentally important Wnt signaling pathway has traditionally been regarded as a critical player in tumorigenesis through the canonical Wnt/β-catenin cascade. Nevertheless, accumulating evidence based on recent research has revealed the previously unacknowledged role of noncanonical Wnt/planar cell polarity (PCP) signaling in cancer progression, invasion and metastasis, and angiogenesis. This review describes the PCP signaling pathway and its ever-expanding components and modulators, highlights the most recent studies that provide insight into the link between PCP signaling and cancer, and, finally, proposes a model by which PCP signaling may promote cancer development. This review underscores the emerging theme that deregulated PCP signaling contributes to tumorigenesis, providing new potential targets for cancer therapy. Copyright © 2009 American Association for Cancer Research.

Cite

CITATION STYLE

APA

Wang, Y. (2009, August 1). Wnt/Planar cell polarity signaling: A new paradigm for cancer therapy. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.MCT-09-0282

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free